Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,337 public trials 2,831 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, Not Recruiting

Study to Evaluate the Reinduction and Second Stop of TKI with Ponatinib in CML in Molecular Response (ResToP)

NCT04160546

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, Chronic Phase, +12 more
Locations
  • Institut Català D'Oncologia L'Hospitalet (ICO) L'Hospitalet de Llobregat, Barcelona, Spain
  • Hospital General Universitario Gregorio Marañón Madrid, Spain
  • Hospital Ramón y Cajal Madrid, Spain
  • Hospital Universitario y Politécnico La Fe Valencia, Spain
View all 13 locations
View Trial Details
Active, Not Recruiting

Study of Acalabrutinib (ACP-196) in Combination With Venetoclax (ABT-199), With and Without Obinutuzumab (GA101) Versus Chemoimmunotherapy for Previously Untreated CLL

NCT03836261

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Redondo Beach, California, United States
  • Research Site Fort Wayne, Indiana, United States
  • Research Site Wichita, Kansas, United States
View all 170 locations
View Trial Details
Active, Not Recruiting

NKX101, Intravenous Allogeneic CAR NK Cells, in Adults With AML or MDS

NCT04623944

Conditions
AML, Adult, Bone Marrow Diseases, Hematologic Diseases, +10 more
Locations
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Mayo Clinic Florida Jacksonville, Florida, United States
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Efficacy and Safety of Ropeginterferon Alfa-2b in Essential Thrombocythaemia Patients

NCT06514807

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations
  • University Hospital Graz, Department of Internal Medicine, Clinical Department of Hematology Graz, Styria, Austria
  • Medical University Innsbruck, Department of Internal Medicine V (Hematology and Oncology) Innsbruck, Tyrol, Austria
  • Ordensklinikum Linz GmbH Elisabethinen Hospital, Department of Internal Medicine I - Hemato-Oncology Linz, Upper Austria, Austria
  • Medical University Vienna, Department of Internal Medicine I, Clinical Department of Hematology and Hemostaseology Vienna, Austria
View all 36 locations
View Trial Details
Active, Not Recruiting

A Study of Gilteritinib Versus Midostaurin in Combination With Induction and Consolidation Therapy Followed by One-year Maintenance in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndromes With Excess Blasts-2 With FLT3 Mutations Eligible for Intensive Chemotherapy

NCT04027309

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations
  • AU-Adelaide-FLINDERS Adelaide, Australia
  • AU-Adelaide-RAH Adelaide, Australia
  • AU-Brisbane-PAH Brisbane, Australia
  • AU-Brisbane-RBWH Brisbane, Australia
View all 193 locations
View Trial Details
Active, Not Recruiting

Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN

NCT03386513

Conditions
Blastic Plasmacytoid Dendritic Cell Neoplasm, Bone Marrow Diseases, Disease Attributes, +25 more
Locations
  • Banner Health MD Anderson Cancer Center Gilbert, Arizona, United States
  • City of Hope Medical Center Duarte, California, United States
  • UCLA Los Angeles, California, United States
  • Stanford Stanford, California, United States
View all 28 locations
View Trial Details
Active, Not Recruiting

A Study Evaluating Gene Therapy With BB305 Lentiviral Vector in Sickle Cell Disease

NCT04293185

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Children's National Hospital Washington D.C., District of Columbia, United States
  • Tufts Medical Center Boston, Massachusetts, United States
  • University of Minnesota Minneapolis, Minnesota, United States
View Trial Details

Related conditions